Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seyda Baydogan

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Ginekologia Polska|December 14, 2016
Comparison of two different antibiotic regimens for the prophylaxisis of cases with preterm premature rupture of membranes: a randomized clinical trialIlker Kahramanoglu, Merve Baktiroglu, Taylan Senol, et al.
Frontiers in Immunology|October 30, 2023
Bacterial and fungal characterization of pancreatic adenocarcinoma from Endoscopic Ultrasound-guided biopsiesRobin D Wright, Thais F Bartelli, Seyda Baydogan, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 25, 2024
Germline Testing Identifies Pathogenic/Likely Pathogenic Variants in Patients with Pancreatic Neuroendocrine TumorsChirayu Mohindroo, Seyda Baydogan, Parul Agarwal, et al.
Cancer Cell|December 29, 2023
Gut epithelial Interleukin-17 receptor A signaling can modulate distant tumors growth through microbial regulationVidhi Chandra, Le Li, Olivereen Le Roux, et al.
Cancer Cell|June 6, 2022
Exercise-induced engagement of the IL-15/IL-15Rα axis promotes anti-tumor immunity in pancreatic cancerEmma Kurz, Carolina Alcantara Hirsch, Tanner Dalton, et al.
The Journal of Experimental Medicine|August 30, 2020
Interleukin-17-induced neutrophil extracellular traps mediate resistance to checkpoint blockade in pancreatic cancerYu Zhang, Vidhi Chandra, Erick Riquelme Sanchez, et al.
Ebiomedicine|November 30, 2018
Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancerPinar Kanlikilicer, Recep Bayraktar, Merve Denizli, et al.
Cancer Medicine|July 12, 2021
Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patientsChirayu Mohindroo, Merve Hasanov, Jane E Rogers, et al.
Endoscopic Ultrasound|July 1, 2024
New-onset diabetes is a predictive risk factor for pancreatic lesions in high-risk individuals: An observational cohort studySeyda Baydogan, Chirayu Mohindroo, Merve Hasanov, et al.
Cancer Discovery|June 26, 2026
Tumor microbial burden drives immune responses through regulation of Interferon signalingHaoyue Liu, Jeong-Hoon Jang, Fuduan Peng, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Ginekologia Polska|December 14, 2016
Comparison of two different antibiotic regimens for the prophylaxisis of cases with preterm premature rupture of membranes: a randomized clinical trialIlker Kahramanoglu, Merve Baktiroglu, Taylan Senol, et al.
Frontiers in Immunology|October 30, 2023
Bacterial and fungal characterization of pancreatic adenocarcinoma from Endoscopic Ultrasound-guided biopsiesRobin D Wright, Thais F Bartelli, Seyda Baydogan, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 25, 2024
Germline Testing Identifies Pathogenic/Likely Pathogenic Variants in Patients with Pancreatic Neuroendocrine TumorsChirayu Mohindroo, Seyda Baydogan, Parul Agarwal, et al.
Cancer Cell|December 29, 2023
Gut epithelial Interleukin-17 receptor A signaling can modulate distant tumors growth through microbial regulationVidhi Chandra, Le Li, Olivereen Le Roux, et al.
Cancer Cell|June 6, 2022
Exercise-induced engagement of the IL-15/IL-15Rα axis promotes anti-tumor immunity in pancreatic cancerEmma Kurz, Carolina Alcantara Hirsch, Tanner Dalton, et al.
The Journal of Experimental Medicine|August 30, 2020
Interleukin-17-induced neutrophil extracellular traps mediate resistance to checkpoint blockade in pancreatic cancerYu Zhang, Vidhi Chandra, Erick Riquelme Sanchez, et al.
Ebiomedicine|November 30, 2018
Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancerPinar Kanlikilicer, Recep Bayraktar, Merve Denizli, et al.
Cancer Medicine|July 12, 2021
Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patientsChirayu Mohindroo, Merve Hasanov, Jane E Rogers, et al.
Endoscopic Ultrasound|July 1, 2024
New-onset diabetes is a predictive risk factor for pancreatic lesions in high-risk individuals: An observational cohort studySeyda Baydogan, Chirayu Mohindroo, Merve Hasanov, et al.
Cancer Discovery|June 26, 2026
Tumor microbial burden drives immune responses through regulation of Interferon signalingHaoyue Liu, Jeong-Hoon Jang, Fuduan Peng, et al.
Pageof 2